FibroBiologics, Inc. (FBLG) SEC Filings https://ir.fibrobiologics.com/sec-filings/all-sec-filings/rss FibroBiologics, Inc. (FBLG) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_14a954ff2903678ce9699bf59a0e1fd9/fibrobiologics/files/theme/images/logo-sm.png FibroBiologics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[8-K - Current report]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-207530/0001193125-26-207530.pdf Wed, 06 May 26 07:04:26 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-207530/0001193125-26-207530.pdf <![CDATA[424B5 - Prospectus [Rule 424(b)(5)]]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-206852/0001193125-26-206852.pdf Wed, 06 May 26 06:01:16 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-206852/0001193125-26-206852.pdf <![CDATA[8-K - Current report]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205044/0001193125-26-205044.pdf Tue, 05 May 26 07:21:44 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205044/0001193125-26-205044.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205037/0001193125-26-205037.pdf Tue, 05 May 26 07:19:57 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205037/0001193125-26-205037.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205035/0001193125-26-205035.pdf Tue, 05 May 26 07:19:16 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205035/0001193125-26-205035.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205032/0001193125-26-205032.pdf Tue, 05 May 26 07:18:30 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-205032/0001193125-26-205032.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021175/0001493152-26-021175.pdf Mon, 04 May 26 19:01:38 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021175/0001493152-26-021175.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021174/0001493152-26-021174.pdf Mon, 04 May 26 19:01:23 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021174/0001493152-26-021174.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021173/0001493152-26-021173.pdf Mon, 04 May 26 19:01:08 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021173/0001493152-26-021173.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021172/0001493152-26-021172.pdf Mon, 04 May 26 19:00:38 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-021172/0001493152-26-021172.pdf